Abbott News

Pharmaceutical News from Abbott Laboratories

The Deal Names Abbott Top Dealmaker for Second Consecutive Year

The Deal Names Abbott Top Dealmaker for Second Consecutive Year

Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform

Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform

Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial

Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial

Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)

Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)

New Web Sites Educate About Triglycerides and HDL Cholesterol

New Web sites Educate about Triglycerides and HDL Cholesterol

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain

President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department

President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department

Abbott Saving 1 Billion Gallons of Water Annually

Abbott Saving 1 Billion Gallons of Water Annually

Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes

Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes

Abbott Completes Acquisition of Evalve, Inc.

Abbott Completes Acquisition of Evalve, Inc.